(EMAILWIRE.COM, June 05, 2018 ) Middle East and Africa Biosimilars Market was worth USD 357.0 million in 2016 and estimated to be growing at a CAGR of 24.96%, to reach USD 1,322.5 million by 2022. Biosimilars are emerging as one of the most important sector in the healthcare industry. With increasing...more
(EMAILWIRE.COM, June 05, 2018 ) Latin America Biosimilars Market was worth USD 580.7 million in 2016 and estimated to be growing at a CAGR of 29.68%, to reach USD 2,646.1 million by 2022. Biosimilars are emerging as one of the most important sector in the healthcare industry. With increasing healthcare...more
(EMAILWIRE.COM, June 05, 2018 ) Global Feed Testing Market was worth USD 569.2 million in 2016 and estimated to be growing at a CAGR of 9.2%, to reach USD 883.85 million by 2021. The Feed Testing market is showing evident potential in the mentioned forecasting period. The market continues to gain...more
(EMAILWIRE.COM, June 05, 2018 ) Asia-Pacific Biosimilars Market was worth USD 785.4 million in 2016 and estimated to be growing at a CAGR of 31.60%, to reach USD 3,908.5 million by 2022. Biosimilars are emerging as one of the most important sector in the healthcare industry. With increasing healthcare...more
(EMAILWIRE.COM, June 05, 2018 ) Europe Biosimilars Market was worth USD 1,775.5 million in 2016 and estimated to be growing at a CAGR of 23.50%, to reach USD 6,109.1 million by 2022. Biosimilars are rapidly growing as one of the most important sectors in the healthcare industry. With increasing healthcare...more
(EMAILWIRE.COM, June 05, 2018 ) The Global Cell Based Assay Market was worth USD 10.5 billion in 2016 and estimated to be growing at a CAGR of 11.2%, to reach USD 17.85 billion by 2021. Cell based assays are majorly used by biotechnology companies, academic research institutes, contract research...more
(EMAILWIRE.COM, June 05, 2018 ) Global Medicated Feed Additives Market became really worth USD 11.3 billion in 2016 and estimated to be developing at a CAGR of 5.Forty three%, to reach USD 14.Seventy two billion by means of 2021. The Medicated Feed Additives market is displaying obtrusive capability...more
(EMAILWIRE.COM, June 05, 2018 ) The Global Liquid Biopsy market is expected to increase at a CAGR of 24.3% in the forecast period of 2017-2022 and reach a value of USD 2176.5 million by 2022 from USD 733.5 million in 2017.
This technology of liquid biopsy has enormous diagnostic and treatment...more
(EMAILWIRE.COM, June 05, 2018 ) North America Biosimilars Market was worth USD 1,261.4 million in 2016 and estimated to be growing at a CAGR of 27.13%, to reach USD 5,168.3 million by 2022. Biosimilars are emerging as one of the most important sector in the healthcare industry. With increasing healthcare...more
(EMAILWIRE.COM, June 05, 2018 ) Global regenerative medicines market is expected to reach USD 48.90 billion by 2021 from USD 17.20 billion in 2016, growing at a CAGR of 23.24% during the forecast period 2016-2021. Regenerative medicines repair, replace or regenerate human cells, tissues, or organs...more
(EMAILWIRE.COM, June 05, 2018 ) The Global Bioreactors Market was worth USD 1019.9 million in 2016 and estimated to be growing at a CAGR of 6.8%, to reach USD 1417 million by 2021. Rising Chronic disease prevalence and increasing biopharmaceutical investments will propel the growth of the market.
A...more
(EMAILWIRE.COM, June 05, 2018 ) The Global Acute Ischemic Stroke Treatment and Diagnosis Market was worth $1814 million in 2015 and estimated to be growing at a CAGR of 6.7%, to reach $2508 million by 2020. Acute Ischemic stroke can be defined as loss of function in certain parts of brain due to...more
(EMAILWIRE.COM, June 05, 2018 ) Biosimilars Market was worth USD 4,760.0 million in 2016 and estimated to be growing at a CAGR of 26.87%, to reach USD 19,154.5 million by 2022. Biosimilars are emerging as one of the most important sector in the healthcare industry. With increasing healthcare costs,...more
(EMAILWIRE.COM, June 05, 2018 ) Global Injectable Drug Delivery Market changed into well worth USD 362.38 billion in 2016 and estimated to be developing at a CAGR of eleven.5%, to attain USD 624.Fifty one billion by way of 2021.
Injectable drug transport technologies permit the transport of drugs...more
(EMAILWIRE.COM, June 05, 2018 ) Antinuclear Antibody Test Market value was worth USD 823.50 million in 2016 and expected to reach USD 1.48 billion by 2021 at a CAGR of 12.40%. The market is showcasing evident potential in the mentioned forecasting period. The antinuclear antibody test is a primary...more
